SCOPUS 정보 검색 플랫폼

Volumn 34, Issue 3, 2000, Pages 673-680

Measuring the pace of new drug development in the user fee era

a TUFTS UNIVERSITY SCHOOL OF MEDICINE (United States)

Author keywords

Drug development; FDA Modernization Act of 1997; Food and Drug Administration; New chemical entity; New drug approval; Pharmaceutical industry; Prescription Drug User Fee Act of 1992

Indexed keywords

NEW DRUG;

ARTICLE; DRUG APPROVAL; DRUG INDUSTRY; DRUG MARKETING; DRUG RESEARCH; FOOD AND DRUG ADMINISTRATION; LAW; PRIORITY JOURNAL; TIME;

EID: 0033846522 PISSN: 00928615 EISSN: None Source Type: Journal
DOI: 10.1177/009286150003400303 Document Type: Article

Times cited : (38)

References (12)

1
- 0008177377
- Prescription Drug User Fee Act of 1992. Public Law 102-571; 21 USC 379;106 Stat 4491
- (1992) , Issue.PART 29

2
- 0030951929
- The Prescription Drug User Fee Act of 1992 and the new drug development process
- (1997) Am J Therapeutics , vol.4 , Issue.5-6 , pp. 167-172
- Kaitin, K.I.¹

3
- 0034045314
- The new drug approvals of 1996, 1997, and 1998: Drug development trends in the user fee era
- (2000) Drug Inf J , vol.34 , Issue.1 , pp. 1-14
- Kaitin, K.I.¹ Healy, E.M.²

4
- 0028455313
- New drug development in the United States, 1963 to 1992
- (1994) Clin Pharmacol Ther. , vol.55 , Issue.6 , pp. 609-622
- DiMasi, J.A.¹ Seibring, M.A.² Lasagna, L.³

5
- 0008261331
- Food and Drug Administration Modernization Act of 1997. Public Law 105-115; 21 USC 355a; 111 Stat 2296
- (1997)

6
- 0030840825
- Initiatives to speed new drug development and regulatory review: The impact of FDA-sponsor conferences
- (1997) Drug Inf J , vol.31 , Issue.3 , pp. 771-788
- DiMasi, J.A.¹ Manocchia, M.²

7
- 0008223187
- Seeking FDA Advice to Speed New Drug Development: The Role of FDA/Sponsor Meetings, a Symposium Organized by the Tufts Center for the Study of Drug Development, January 27, 1999, Philadelphia, PA. Executive Summary. Boston, MA: Tufts CSDD
- (1999)

8
- 0008262415
- Effective data use drives portfolio management and global strategies. Boston, MA: Tufts Center for the Study of Drug Development Impact Report
- (2000) , vol.2 , Issue.1

9
- 0025868362
- Cost of innovation in the pharmaceutical industry
- (1991) J Health Econ. , vol.10 , Issue.2 , pp. 107-142
- DiMasi, J.A.¹ Hansen, R.W.² Grabowski, H.G.³ Lasagna, L.⁴

10
- 0008220362
- Final annual performance report: Prescription Drug User Fee Act of 1992: fiscal year 1997 report to Congress. Rockville, MD: Food and Drug Administration
- (1997)

11
- 0008217932
- FY 1998 performance report to Congress for the Prescription Drug User Fee Act of 1992 as amended by the Food and Drug Administration Modernization Act of 1997

12
- 0008179707
- Pharma 2005: an industrial revolution in R and D. London: PriceWaterhouseCoopers
- (1998)

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.